Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Calcitriol50 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A01072 | 34878523 | Endocrinology | Adipose-specific VDR Deletion Leads to Hepatic Steatosis in Female Mice Fed a Low-Fat Diet. | 2022 | Details |
| A01804 | 34609237 | Health Informatics J | Trend research of vitamin D receptor: Bibliometric analysis. | 2021 | Details |
| A02299 | 34431511 | Cochrane Database Syst Rev | Vitamin D supplementation for chronic liver diseases in adults. | 2021 | Details |
| A02319 | 34421816 | Front Endocrinol (Lausanne) | Vitamin D Level and Vitamin D Receptor Genetic Variation Were Involved in the Risk of Non-Alcoholic Fatty Liver Disease: A Case-Control Study. | 2021 | Details |
| A03896 | 33827700 | BMC Pharmacol Toxicol | The efficacy of calcitriol treatment in non-alcoholic fatty liver patients with different genotypes of vitamin D receptor FokI polymorphism. | 2021 | Details |
| A04992 | 33421970 | Turk J Med Sci | The effect of 1,25-dihydroxyvitamin D3 on liver damage, oxidative stress, and advanced glycation end products in experimental nonalcoholic- and alcoholic- fatty liver disease | 2021 | Details |
| A05191 | 33341312 | Clin Nutr | A randomized controlled clinical trial comparing calcitriol versus cholecalciferol supplementation to reduce insulin resistance in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A05752 | 33132636 | World J Gastroenterol | Is vitamin D receptor a druggable target for non-alcoholic steatohepatitis? | 2020 | Details |
| A05767 | 33126575 | Nutrients | Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update. | 2020 | Details |
| A06446 | 32879216 | Biol Pharm Bull | A Lipid-Based Nanocarrier Containing Active Vitamin D3 Ameliorates NASH in Mice via Direct and Intestine-Mediated Effects on Liver Inflammation. | 2020 | Details |
| A07411 | 32510837 | Liver Int | Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity. | 2020 | Details |
| A08583 | 32051143 | J Biol Chem | Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease. | 2020 | Details |
| A08594 | 32045698 | Biochim Biophys Acta Mol Cell Biol Lipids | Imbalanced insulin substrate-1 and insulin substrate-2 signaling trigger hepatic steatosis in vitamin D deficient rats: 8-methoxypsoralen, a vitamin D receptor ligand with a promising anti-steatotic action. | 2020 | Details |
| A08788 | 31984787 | Am J Physiol Gastrointest Liver Physiol | Vitamin D signaling maintains intestinal innate immunity and gut microbiota: potential intervention for metabolic syndrome and NAFLD. | 2020 | Details |
| A09858 | 31589177 | Curr Opin Clin Nutr Metab Care | Vitamin D and nonalcoholic fatty liver disease. | 2019 | Details |
| A10056 | 31506976 | Hepatology | Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice. | 2020 | Details |
| A10174 | 31454158 | Mol Nutr Food Res | Tomatidine Reduces Palmitate-Induced Lipid Accumulation by Activating AMPK via Vitamin D Receptor-Mediated Signaling in Human HepG2 Hepatocytes. | 2019 | Details |
| A10571 | 31284538 | Molecules | The Modulatory Action of Vitamin D on the Renin-Angiotensin System and the Determination of Hepatic Insulin Resistance. | 2019 | Details |
| A11412 | 30905785 | Biochim Biophys Acta Mol Basis Dis | Intestinal vitamin D receptor modulates lipid metabolism, adipose tissue inflammation and liver steatosis in obese mice. | 2019 | Details |
| A11578 | 30832722 | Trials | Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial. | 2019 | Details |
| A11595 | 30825110 | Dig Dis Sci | Antifibrotic Effects of 1,25(OH)2D3 on Nonalcoholic Steatohepatitis in Female Mice. | 2019 | Details |
| A11914 | 30683615 | Dig Liver Dis | Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease. | 2019 | Details |
| A12871 | 30248338 | Am J Pathol | Angiopoietin-Like Protein 8 Is a Novel Vitamin D Receptor Target Gene Involved in Nonalcoholic Fatty Liver Pathogenesis. | 2018 | Details |
| A13777 | 29761652 | Pediatr Obes | Vitamin D status and associated genetic polymorphisms in a cohort of UK children with non-alcoholic fatty liver disease. | 2018 | Details |
| A13929 | 29684027 | PLoS One | Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model. | 2018 | Details |
| A13996 | 29653100 | Chem Biol Interact | Vitamin D nanoemulsion enhances hepatoprotective effect of conventional vitamin D in rats fed with a high-fat diet. | 2018 | Details |
| A14099 | 29588137 | Diabetes Metab Syndr | Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial. | 2018 | Details |
| A15093 | 29099543 | Cochrane Database Syst Rev | Vitamin D supplementation for chronic liver diseases in adults. | 2017 | Details |
| A15372 | 28941597 | Metabolism | Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitis. | 2017 | Details |
| A16147 | 28539530 | Endocr J | Active form of vitamin D ameliorates non-alcoholic fatty liver disease by alleviating oxidative stress in a high-fat diet rat model. | 2017 | Details |
| A17396 | 27644736 | Am J Gastroenterol | Vitamin D is Not Associated With Severity in NAFLD: Results of a Paired Clinical and Gene Expression Profile Analysis. | 2016 | Details |
| A17608 | 27720403 | Clin Nutr | Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial. | 2016 | Details |
| A17734 | 27631178 | Arch Iran Med | Regression of Non-Alcoholic Fatty Liver by Vitamin D Supplement: A Double-Blind Randomized Controlled Clinical Trial. | 2016 | Details |
| A18281 | 27245430 | J Hepatol | Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis. | 2016 | Details |
| A18767 | 26959059 | Nutrients | The Potential Protective Action of Vitamin D in Hepatic Insulin Resistance and Pancreatic Islet Dysfunction in Type 2 Diabetes Mellitus. | 2016 | Details |
| A20635 | 25843661 | Nutr Metab Cardiovasc Dis | A role of 1,25(OH)2D3 supplementation in rats with nonalcoholic steatohepatitis induced by choline-deficient diet. | 2015 | Details |
| A21580 | 25214402 | Am J Physiol Gastrointest Liver Physiol | Vitamin D deficiency promotes nonalcoholic steatohepatitis through impaired enterohepatic circulation in animal model. | 2014 | Details |
| A21671 | 25134788 | Gut | Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently. | 2014 | Details |
| A22830 | 24275855 | Curr Opin Oncol | Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer. | 2014 | Details |
| A24554 | 22753133 | Hepatology | Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. | 2012 | Details |
| A24666 | 22634121 | J Hepatol | D-livering the message: the importance of vitamin D status in chronic liver disease. | 2012 | Details |
| A25098 | 22173168 | J Hepatol | The interaction of hepatic lipid and glucose metabolism in liver diseases. | 2011 | Details |
| A25806 | 21440524 | Clin Res Hepatol Gastroenterol | Vitamin D and the vitamin D receptor in liver pathophysiology. | 2011 | Details |
| A42503 | 34358825 | Clin Nutr | Effect of supplementation with calcitriol versus cholecalciferol on insulin resistance in patients with nonalcoholic fatty liver disease: Several issues of concern. | 2021 | Details |
| A42540 | 34202146 | Biomolecules | Molecular Initiating Events Associated with Drug-Induced Liver Malignant Tumors: An Integrated Study of the FDA Adverse Event Reporting System and Toxicity Predictions. | 2021 | Details |
| A45050 | 26294696 | Gut | High-dose vitamin D supplementation and liver histology in NASH. | 2015 | Details |
| A45323 | 25192564 | Gut | Vitamin D and liver fibrosis: let's start soon before it's too late. | 2014 | Details |
| A46888 | 11303985 | Dig Liver Dis | Concurrent non-alcoholic steatohepatitis and psoriasis. Report of three cases from the POLI.ST.E.N.A. study. | 2001 | Details |
| A48637 | 32616182 | Bioorg Med Chem | N1-Substituted benzimidazole scaffold for farnesoid X receptor (FXR) agonists accompanying prominent selectivity against vitamin D receptor (VDR). | 2020 | Details |
| A48815 | 27728806 | Cancer Cell | p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer. | 2016 | Details |